Y
Yonghong Xiao
Researcher at Zhejiang University
Publications - 144
Citations - 3202
Yonghong Xiao is an academic researcher from Zhejiang University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 24, co-authored 110 publications receiving 1978 citations.
Papers
More filters
Journal ArticleDOI
Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis
Longxian Lv,Daiqiong Fang,Ding Shi,Deying Chen,Ren Yan,Yixin Zhu,Yanfei Chen,Li Shao,Feifei Guo,Wenrui Wu,Ang Li,Haiyan Shi,Xiawei Jiang,Huiyong Jiang,Yonghong Xiao,Shu-Sen Zheng,Lanjuan Li +16 more
TL;DR: The gut microbiome is altered and may be critical for the onset or development of PBC by interacting with metabolism and immunity, and several altered gut bacterial taxa exhibited potential interactions with PBC through their associations with altered metabolism, immunity and liver function indicators.
Journal ArticleDOI
Epidemiology and characteristics of antimicrobial resistance in China.
TL;DR: The molecular characteristics of MRSA, ESBL- and carbapenemase-producing Enterobacteriaceae, and macrolide-resistant gram-positive Streptococci in China were significantly different from those in other countries and regions, while S. pneumoniae serotypes appear to have been affected by the global spread of prevalent clones in other parts of the world.
Journal ArticleDOI
Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals.
TL;DR: This study revealed that the widespread prevalence of ESBLs among outpatient infections has reached a high level in county hospitals and the CTX-M genotype was most dominant, comprising a variety of subtypes.
Journal ArticleDOI
changes in chinese policies to promote the rational use of antibiotics
TL;DR: A government strategy to promote rational use of antimicroBials in health care reduced antibiotic sales and percentage of prescriptions for antimicrobials for both hospitalized patients and outpatients, and offers insights to shape future initiatives.